All insights · Economics

Why Margin per Case May Not Be Enough

Margin per case says what one episode is worth. It does not say what the bed, the room and the team could be worth if the episode were shorter. Surgical economics needs a second denominator.

By ONE AXIS · 2027-03 · 7 min read

Executive tension

The financial reading of a surgical line usually stops at one number: margin per case — or its cousin, margin percentage. It is a useful number. It is a sufficient one only when the resources each case consumes are fixed. In surgery they are not. Two arthroplasties can generate the same margin and use very different amounts of bed, ICU and operating-room time. When leadership evaluates a redesign of the surgical journey with margin per case alone, it can reach the wrong conclusion in either direction: rejecting a change that made the hospital more productive because the margin per episode fell, or celebrating a change that raised margin per case while it quietly consumed more capacity.

Why that can be wrong

In a prior founder-led hip arthroplasty programme in a private hospital, the usual-care baseline showed a mean stay of 11.4 days with 47 % post-operative ICU use. After the journey was redesigned with one surgical team, mean stay fell to 1.7 days and ICU use to 20 %. Read with margin per case, the result looked like a loss: absolute net margin per episode fell from R$ 22,623 to R$ 11,566, with margin percentage stable at around 28 %. Read with a second denominator — net margin per occupied bed-day — the same episodes went from R$ 1,984 to R$ 6,804. Neither number is wrong. They answer different questions. The first asks what one episode is worth; the second asks what a day of the hospital's scarce capacity is worth when it is used for this line. The change did not make each case more profitable, and no one should claim it did. It made each bed-day used for this surgery considerably more productive, and released — for every patient — the difference between the two stays for other uses. A prior bariatric programme shows the mirror image. Contribution margin per episode was 34.7 % before and 33.0 % after implementation — no demonstrated increase — while payer cost per episode fell 12.4 %, hospital variable cost per episode fell 16.4 %, and the nine-hour shorter stay released roughly 49.5 bed-days across the post-implementation cohort. A margin-percentage reading says nothing changed. A value reading says the payer paid less, the hospital spent less per case and capacity was released — none of it monetized, because the commercial agreement did not change.

ONE AXIS reframe

Margin per case measures the episode. Surgical value is produced by the journey and consumed as capacity. ONE AXIS reads the economics of a surgical line with two denominators at once — per case and per unit of scarce capacity: bed-day, ICU-day, operating-room hour — and does not let either one speak alone. Per case protects against the illusion of productivity that hides a real loss of revenue; per capacity protects against the illusion of stability that hides a real gain in productivity. The economic model of the line, and the commercial agreement with the payer, are then designed so that what the journey creates can actually be captured.

Framework

Three readings, in order. First, the episode: revenue, total cost and net margin per case, with a cost method that is identical before and after — a fully loaded cost in both phases, or a variable cost in both, never one on each side. Second, the capacity: the same margin divided by the mean number of bed-days (and, where relevant, ICU-days and operating-room hours) the episode consumes; this is the productivity of the hospital's scarce resource when it is used for this line. Third, the option: what the released capacity is used for. Released capacity has no monetary value until it is filled with cases the hospital could not previously admit, removed from the cost base, or reflected in a commercial agreement that shares the gain with the payer. Until one of those three happens, the second reading is a capacity-productivity signal — not profit. Reporting it as profit is the most common way a good programme loses credibility with a finance director.

Executive implication

When a surgical redesign is presented to you, ask for both denominators and for the story between them. If margin per case fell and margin per bed-day rose, the question is not whether the programme failed; it is whether the released capacity has a destination, and whether the payer contract rewards a shorter, safer journey or penalizes it. If margin per case rose and margin per bed-day did not, ask what consumed the capacity. And if a team tells you the line became “several times more profitable”, ask to see the absolute margin per episode alongside — because the honest reading always shows both. The practical discipline: no economic result declared without the two denominators side by side; no capacity gain counted as money until it has a destination; no commercial negotiation opened without knowing which of the two readings the payer will use.

Measurement consequence

Report the Economic Delta of a surgical line as a pair: net margin per episode and net margin per occupied bed-day — same cost method, same period, same population, side by side — and label the second as capacity productivity, never as profitability. Add the destination of released capacity as an explicit line, even when it reads “not yet allocated”. And keep the Clinical Delta and the Flow Delta in the same table: a bed-day margin that rose because the stay was shortened at the expense of readmissions is not value; it is cost transferred to the next admission.

Closing question

For your highest-volume surgical line, does your leadership know the net margin per occupied bed-day — and where the last released bed-day went?

Executive Conversation